iifl-logo

Emcure Pharmaceuticals Ltd Share Price Live

1,414.3
(0.21%)
Nov 28, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open1,411
  • Day's High1,434.4
  • 52 Wk High1,519.9
  • Prev. Close1,411.4
  • Day's Low1,398.1
  • 52 Wk Low 889
  • Turnover (lac)2,012.03
  • P/E61.98
  • Face Value10
  • Book Value172.23
  • EPS22.83
  • Mkt. Cap (Cr.)26,810.16
  • Div. Yield0.21
View All Historical Data

No Record Found

Loading...

Emcure Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

1,411

Prev. Close

1,411.4

Turnover(Lac.)

2,012.03

Day's High

1,434.4

Day's Low

1,398.1

52 Week's High

1,519.9

52 Week's Low

889

Book Value

172.23

Face Value

10

Mkt Cap (₹ Cr.)

26,810.16

P/E

61.98

EPS

22.83

Divi. Yield

0.21

Emcure Pharmaceuticals Ltd Corporate Action

3 Nov 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

1 Aug 2025

12:00 AM

AGM

Announcement Date: 01 Aug, 2025

arrow

22 May 2025

12:00 AM

Dividend

Dividend Amount: 3

Record Date: 14 Aug, 2025

arrow

Emcure Pharmaceuticals Ltd NEWS AND UPDATE

Top Stocks for Today - 18th November 2025

Here are some of the stocks that may see significant price movement today: Emcure Pharma, Tata Power, One 97 Communications, etc.

18 Nov 2025|06:55 AM
Read More
BC Investments to pare 2% stake in Emcure Pharma via block deal

The price stated is a discount of about 7% to Emcure Pharma’s closing price of ₹1,394.10 on the NSE on November 17, 2025.

17 Nov 2025|11:00 PM
Read More
Novo Nordisk Expands Obesity-Care Reach in India with Emcure Pharma Collaboration

This is a second brand of Wegovy® (semaglutide injection 2.4 mg), in a move aimed at expanding access to its anti-obesity therapy across the country.

10 Nov 2025|03:02 PM
Read More
Top Stocks for Today - 17th July 2025

Here are some of the stocks that may see significant price movement today: Tech Mahindra, L&T Technology, Maruti Suzuki, etc.

17 Jul 2025|06:22 AM
Read More
Emcure Set to Acquire Remaining Stake in Zuventus for ₹724.9 Crore

According to Emcure, the deal was cleared by its board and will be settled in cash. The payments may happen in one or more parts, depending on the closure timeline.

21 Jun 2025|08:00 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Emcure Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

29 Nov, 2025|06:16 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.23%

Foreign: 0.22%

Indian: 77.65%

Non-Promoter- 7.65%

Institutions: 7.65%

Non-Institutions: 14.45%

Custodian: 0.00%

Share PriceShare Price

Emcure Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2025Mar-2024Mar-2023Mar-2022

Equity Capital

189.48

181.15

180.85

180.85

Preference Capital

0

0

0

0

Reserves

2,834.88

1,753.95

1,661.02

1,531.68

Net Worth

3,024.36

1,935.1

1,841.87

1,712.53

Minority Interest

View Balance Sheet

No Record Found

No Record Found

No Record Found

Particulars (Rupees in Crores.)Mar-2025Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

7,896

6,658.25

5,985.81

5,855.39

6,056.42

Excise Duty

0

0

0

0

0

Net Sales

7,896

6,658.25

5,985.81

5,855.39

6,056.42

Other Operating Income

0

0

0

0

0

Other Income

67.26

56.99

45.91

63.47

35.39

Emcure Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,810.3

92.894,34,159.66564.220.884,511.2799.24

Divis Laboratories Ltd

DIVISLAB

6,490.5

68.531,72,287.786960.462,660578.26

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,730.4

59.241,26,434.155970.162,707249.83

Cipla Ltd

CIPLA

1,525.2

23.691,23,148.761,210.531.054,495.16411.56

Dr Reddys Laboratories Ltd

DRREDDY

1,249.3

19.331,04,369.38387.30.644,602.9377.56

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Emcure Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Whole Time Director

MUKUND KESHAO GURJAR

Whole Time Director

SUNIL RAJNIKANT MEHTA

Managing Director & Chief Executive Officer

SATISH RAMANLAL MEHTA

Chairman (Non-Executive)

Berjis M Desai

Whole Time Director

NAMITA VIKAS THAPAR

Independent Director

P S Jayakumar

Independent Director

Vijay Gokhale

Independent Director

Vidya Rajiv Yeravdekar

Independent Director

Shailesh Ayyangar

Whole-time Director

SAMIT SATISH MEHTA

Registered Office

Plot # P-1 & P-2 IT BT Park,

Phase II MIDC Hinjawadi,

Maharashtra - 411057

Tel: +91 20 3507 0033/+91 20 3507 0000

Website: http://www.emcure.com

Email: investors@emcure.com

Registrar Office

C-101 247 Park,

L B S Marg, Vikhroli West,

Mumbai-400083

Tel: 91-22-49186000

Website: www.linkintime.co.in

Email: paytm.ipo@linkintime.co.in

Summary

Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited, as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Re...
Read More

Company FAQs

What is the Emcure Pharmaceuticals Ltd share price today?

The Emcure Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1414.3 today.

What is the Market Cap of Emcure Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Emcure Pharmaceuticals Ltd is ₹26810.16 Cr. as of 28 Nov ‘25

What is the PE and PB ratio of Emcure Pharmaceuticals Ltd?

The PE and PB ratios of Emcure Pharmaceuticals Ltd is 61.98 and 8.35 as of 28 Nov ‘25

What is the 52 Week High and Low of Emcure Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Emcure Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Emcure Pharmaceuticals Ltd is ₹889 and ₹1519.9 as of 28 Nov ‘25

What is the CAGR of Emcure Pharmaceuticals Ltd?

Emcure Pharmaceuticals Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 2.38%, 6 Month at 3.84%, 3 Month at -1.42% and 1 Month at 4.63%.

What is the shareholding pattern of Emcure Pharmaceuticals Ltd?

The shareholding pattern of Emcure Pharmaceuticals Ltd is as follows:
Promoters - 77.88 %
Institutions - 7.66 %
Public - 14.46 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.